Supplier · Peer benchmark
Peer comparison
How Bowel Cancer Screening Midlands and North West stacks up against suppliers competing for the same workloads — based on overlap with its 1 signature CPV code over the last 24 months.
Value band:
/
CohortBowel Cancer Screening Midlands and North West(You)PricewaterhouseCoopers LLPPreventx LimitedSheffield Teaching Hospitals NHS Foundation TrustOrchid Cellmark Ltd (t/a Cellmark Forensic Services)UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST
iAuto-picked from 1 signature CPV code · last 24 months overlap
Metric | PR PricewaterhouseCoopers LLP Peer · rank #1 | PR Preventx Limited Peer · rank #2 | ST Sheffield Teaching Hospitals NHS Foundation Trust Peer · rank #3 | BC Bowel Cancer Screening Midlands and North West (You) · target supplier | OC Orchid Cellmark Ltd (t/a Cellmark Forensic Services) Peer · rank #5 | UH UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST Peer · rank #6 |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £92.7m | £2.0m | £1.3m | — | — | — |
| Framework headroomPer-supplier share of framework ceilings | £1.2m | — | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £1.1bn | £222.4m | £658.1m | — | £10.4m | £438.5m |
| Contracts won (12m)Distinct awards last year | 65 | 2 | 7 | — | — | — |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —